The Patent Finder

Regenxbio Inc.

Also on record
Records under this name other than the patents Regenxbio Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 6 of 6 · Back to Regenxbio Inc.

PatentTitleStatus Expires Confidence
US 9,827,295Methods to Treat Mucopolysaccharide Type I or Deficiency in Alpha-L-Iduronidase Using a Recombinant Adeno-Associated Virus Encoding Alpha-L-Iduronidase
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,121,567Methods to Treat Mucopolysaccharidosis Type II or Deficiency in IDURONATE-2-Sulfatase Using a Recombinant Adeno-Associated Virus (AAV) Vector Encoding IDURONATE-2-Sulfatase
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,070,510Injection of Single-Stranded or Self-Complementary Adeno-Associated Virus 9 into the Cerebrospinal Fluid
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,613,739Treatment of Mucopolysaccharidosis II with Recombinant Human IDURONATE-2-Sulfatase (IDS) Produced by Human Neural or Glial Cells
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,986,515Treatment of Mucopolysaccharidosis II with Recombinant Human IDURONATE-2-Sulfatase (IDS)
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,247,213Treatment of mucopolysaccharidosis IVA
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited